Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/MYND stock hub

CSE/MYND has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/MYNDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/MYND

In the news

Latest news · CSE/MYND

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/MYND market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

131

Groups with data

Currency

CAD

Showing 131 of 131 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 8.2M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA62857B1094
Last refreshed	2026-05-10
Market cap	CAD 5.2M
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/MYND
Website	https://www.myndsciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.4%
EV Earnings	-15.15x
P/B ratio	-0.87x
P/S ratio	5,218,346x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	CAD -331,778
Net Income	CAD -542,565
Net Income Growth Quarters	8%
Pretax Margin	-54,256,500%
ROA	-151.5
ROCE	21.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	100.1%
Cagr3y	-20.63%
EPS Growth Quarters	8

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0
Assets	CAD 719,718
Cash	CAD 497
Current Assets	CAD 614,631
Current Liabilities	CAD 6.7M
Debt	CAD 3M
Equity	CAD -6M
Interest Coverage	-5.47
Liabilities	CAD 6.7M
Long Term Assets	CAD 105,087
Long Term Liabilities	CAD 0
Net Cash	CAD -3M
Net Cash By Market Cap	CAD -57.48
Tangible Book Value	CAD -6M
Tangible Book Value Per Share	CAD -0.13
WACC	8.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.09
Net Working Capital	CAD -3.1M
Quick ratio	0.09
Working Capital	CAD -6.1M
Working Capital Turnover	CAD 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	100%
200-day SMA	0.05
3Y total return	-50%
50-day SMA	0.08
50-day SMA vs 200-day SMA	50over200
All Time High	2.5
All Time High Change	-97.2%
All Time High Date	2021-05-26
All Time Low	0.01
All Time Low Change	1,300%
All Time Low Date	2023-10-20
ATR	0.02
Beta	0.96
Beta1y	0
Beta2y	-0.1
Ch YTD	-30
High	0.07
High52	0.14
High52 Date	2024-11-18
High52ch	-50%
Low	0.03
Low52	0.01
Low52 Date	2024-10-02
Low52ch	600%
Ma50ch	-12.83%
Price vs 200-day SMA	55.21%
RSI	49.06
RSI Monthly	36.34
RSI Weekly	52.04
Sharpe ratio	2.55x
Sortino ratio	6.32
Total Return	0.92%
Tr YTD	-30
Tr1m	133.33%
Tr3m	-36.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -1.3M
Operating margin	-128,598,000

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Out	74,547,806
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	7,481.85x
Bv Per Share	-0.13
Ch1m	133.3
Ch1y	100
Ch3m	-36.36
Ch3y	-50
Ch6m	133.3
Change	0%
Change From Open	133.3
Close	0.07
Days Gap	-57.14
Depreciation Amortization	2,280
Dollar Volume	140
Earnings Date	2026-06-30
EBIT	CAD -1.3M
EBITDA	CAD -1.3M
EPS	CAD -0.01
F Score	2
Financing CF	-50,000
Fiscal Year End	October
Investing CF	223,101
Is Primary Listing	1
Last Earnings Date	2025-09-30
Last Report Date	2024-07-31
Ma150	0.05
Ma150ch	44.33%
Ma20	0.08
Ma20ch	-7.04%
Net CF	326
Next Earnings Date	2026-06-30
Open	0.03
Position In Range	100
Ppne	5,087
Price Date	2025-04-22
Relative Volume	0.27x
Revenue	1x
SBC By Revenue	2,287,800x
Share Based Comp	22,878
Tr6m	133.33%
Volume	2,000
Z Score	-36.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/MYND pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/MYND stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

CSE/MYND momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.1

Neutral momentum band

Price vs 200-day MA

+55.2%

50/200-day relationship not available

Beta (5Y)

0.96

Moves roughly with the market

Sharpe ratio

2.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/MYND

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/MYND stock rating?

cse/MYND is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/MYND analysis?

The full report lives at /stocks/cse/MYND/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/MYND?

The latest report frames cse/MYND around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/MYND page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.